$DLB

Dolby Laboratories (DLB) CAO sells 1,183 Class A shares

Dolby Laboratories (DLB) reported that Ryan Nicholson, VP and CAO, sold 1,183 shares of Class A Common Stock on 2026-08-25 at $65.2773 per share. Nicholson now holds 34,453 shares, including 19,303 restricted stock units. The sale was not part of a Rule 10b5-1 trading plan.

Original reporting
Published Aug 28, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 5:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$DLB
Neutral
high confidence
Mentioned
$DLB
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$DLBNeutralLow
01

Why it matters

The modest insider transaction provides limited new information for traders; it does not alter the company's fundamentals.

02

Market read

Minor insider sell; unlikely to move the stock significantly.

03

What to watch

No 10b5‑1 plan was indicated, suggesting the sale was discretionary.

Relevance 4/10Novelty 4/10Timing: post‑market 2026‑08‑25

Background

Dolby Laboratories (DLB) filed a Form 4 reporting an insider sale by its VP/CAO.

Company-level read

Ticker impact

$DLBNeutralHigh confidence
Context

Dolby Laboratories VP and CAO Ryan Nicholson sold 1,183 Class A shares at $65.28 on 2026-08-25, reducing his holdings to 34,453 shares.

Expected impact

Minimal, likely negligible effect on DLB stock price.

Evidence & confidence

The transaction size (~$77K) is modest relative to market cap and does not signal a material change in insider confidence.

Market effects

None; the sale is company‑specific and does not affect the broader audio‑technology sector.

None; limited to Dolby shareholders.

Low; no broader market impact.

Counterpoint

The sale could be viewed as a routine liquidity event rather than a negative signal.

Key entities

  • Ryan Nicholson

    Vice President, Chief Accounting Officer and Corporate Controller at Dolby Laboratories.

Related articles

$DLBMed

Dolby Laboratories, Inc. Q3 2026 Earnings Call Summary

Dolby Laboratories’ Q3 2026 earnings call said it is shifting toward content platforms and usage-based revenue, targeting 10% of total revenue from partners by FY2028. Management cited traction for its Video Distribution Program, including Meta and Alibaba deals, and a China-first automotive strategy. Q4 guidance calls for 23% YoY revenue growth, with a $4M restructuring charge and a $350M share repurchase authorization increase.

$DLBMed

Why Dolby Labs Stock Popped Today

Dolby Laboratories (NYSE: DLB) shares rose 11.7% by 10:45 a.m. ET after its fiscal Q3 2026 results. The company reported revenue of $305 million versus an estimated $312 million, and EPS of $0.69 versus $0.67 expected. GAAP EPS was $0.30. Dolby guided Q4 sales to $362 million-$392 million and full-year revenue to at least $1.4 billion.

$DLBMedAI 8/10

Dolby (DLB) Q3 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Peter L. Goldmacher Chief Executive Officer - Kevin J. Yeaman Chief Financial Officer - Robert J. Park TAKEAWAYS Revenue -- $305 million, falling within management guidance ranges despite timing-related impacts in foundational audio. Non-GAAP EPS -- $0.69, exceeding the midpoint of guidance as lower operating expenses helped offset revenue shifts.

$DLBMed

Dolby Laboratories (NYSE:DLB) Misses Q2 CY2026 Sales Expectations

Audio and video technology company Dolby Laboratories (NYSE: DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $377 million at the midpoint, or 7.4% above analysts’ estimates. Its non-GAAP profit of $0.69 per share was 3% above analysts’ consensus estimates. Is now the time to buy Dolby Laboratories?

$DLBHighAI 9/10

Dolby Laboratories Reports Third Quarter 2026 Financial Results

Copyright 2026 PR Newswire. All Rights Reserved 2026-07-30 SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.

$DLBHigh

Dolby Laboratories, Inc. (DLB): Results of Operations and Financial Condition

Dolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Dolby Laboratories Reports Third Quarter 2026 Financial Results SAN FRANCISCO, July 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the third quarter of fiscal 2026. “We continue to execute against our full-year obje